The Most Commonly Denied Dermatology CPT® Codes

The billing risks behind high-denial dermatology services

Read Time: 3 minutes
May 20, 2026

Commonly denied CPT codes in dermatology often involve biopsies, lesion destruction, excisions, E/M visits, Mohs surgery, and treatment services that require precise documentation, medical necessity support, modifier accuracy, and payer-specific billing alignment. Dermatology practices see high patient volume and often perform multiple services during one encounter, which creates more opportunities for claims to deny when the record does not clearly support what was billed.

Denials are usually not caused by one isolated error. They often reflect recurring workflow gaps involving documentation, diagnosis selection, modifier use, charge capture, prior authorization, payer rules, or cosmetic-versus-medical necessity distinctions. When practices understand which dermatology CPT® codes are most vulnerable, they can reduce avoidable rework and protect reimbursement before claims reach denial status.

Denial Snapshot

Common dermatology denial pattern: The payer cannot clearly connect the CPT® code, diagnosis code, clinical findings, lesion details, modifier usage, and medical necessity documentation.

Most Common Dermatology CPT® Codes Associated With Denials

Denial frequency varies by payer, region, benefit design, and practice mix, but several dermatology code families commonly appear in denial reviews. These codes often involve procedures performed on the same day as an office visit, services with lesion counts or measurements, or treatments that payers may review for medical necessity.

CPT® Code	Dermatology Service	Common Denial Drivers
99213, 99214	Established Patient E/M Visits	Modifier 25, insufficient support for separate E/M service
11102, 11103	Tangential Skin Biopsy	Add-on code errors, lesion documentation, diagnosis support
11104, 11105	Punch Skin Biopsy	Incorrect biopsy type, missing lesion details
17000, 17003, 17004	Destruction of Premalignant Lesions	Lesion count, diagnosis support, payer frequency limits
17110, 17111	Destruction of Benign Lesions	Cosmetic classification, missing medical necessity
11400-11446	Benign Lesion Excision	Size, margin, site, pathology, and diagnosis mismatch
11600-11646	Malignant Lesion Excision	Pathology support, anatomic site, size documentation
17311, 17312	Mohs Micrographic Surgery	Stage documentation, pathology support, medical necessity
96910, 96912, 96913	Phototherapy	Frequency limits, diagnosis support, treatment history
10060, 10061	Incision and Drainage	Procedure complexity, documentation, bundled E/M concerns

These codes show why dermatology billing requires close coordination between clinical documentation and revenue cycle workflows. One missed lesion count, unclear biopsy technique, unsupported modifier, or diagnosis mismatch can delay payment and create unnecessary follow-up.

Dermatology Denials Often Follow Predictable Patterns

Biopsy codes, lesion destruction codes, excision codes, and E/M services often deny for documentation, modifier, medical necessity, or payer policy issues.

Guarantee: We’ll help identify the denial trends affecting your dermatology revenue cycle.

Learn About Our Dermatology Billing Services

Documentation and Medical Necessity Denials

Many dermatology denials begin with incomplete documentation. Payers may ask whether the diagnosis supports the procedure, whether the service was medically necessary, and whether the claim matches the note. This is especially important for biopsies, lesion destruction, benign lesion removal, excisions, Mohs surgery, phototherapy, and same-day E/M services.

Documentation Reminder

Dermatology notes should clearly support: lesion location, lesion count, size when required, symptoms, diagnosis, procedure method, medical necessity, pathology follow-up, and treatment plan.

Biopsy Documentation Gaps

Skin biopsy codes can deny when the note does not specify whether the biopsy was tangential, punch, or incisional. Add-on biopsy codes may also deny when multiple lesions are not clearly documented. A payer reviewing the claim should be able to identify the lesion, the technique, the clinical concern, and the number of biopsies performed.

Code Group	Common Billing Challenge	Denial Prevention Step
11102, 11103	Tangential biopsy and additional lesion reporting	Document technique, site, and number of lesions
11104, 11105	Punch biopsy and add-on code use	Confirm biopsy type and separate lesion count
11106, 11107	Incisional biopsy documentation	Describe depth, location, and diagnostic purpose

Practices that strengthen medical necessity documentation are often better positioned to defend dermatology claims during payer review. Strong documentation also helps billing teams determine whether a claim should be corrected, appealed, or written off under payer policy.

Cosmetic Versus Medically Necessary Services

Benign lesion destruction, skin tag removal, laser services, and other appearance-related procedures may be denied when the payer views the service as cosmetic. The record should explain symptoms or clinical findings such as bleeding, irritation, inflammation, pain, infection risk, obstruction, or functional impairment when those factors support medical necessity.

Compliance Reminder

Key distinction: A service can be clinically appropriate and still deny if the payer policy classifies it as cosmetic or non-covered without specific documentation.

Modifier 25, Bundling, and Same-Day Service Denials

Dermatology encounters frequently include an office visit and a procedure on the same date. Modifier 25 may be appropriate when the E/M service is significant and separately identifiable from the procedure, but payers often deny claims when the note does not clearly support that distinction.

Same-day billing also creates bundling risk. A biopsy, cryotherapy, injection, incision and drainage, or excision may be billed with another service, but the documentation must show why each service was distinct. Without that support, payers may bundle the services or deny part of the claim.

Modifier	Common Dermatology Use	Potential Denial Issue
25	Separate E/M service on same day as procedure	Insufficient support for separate evaluation
59	Distinct procedural service	Documentation does not support separation
51	Multiple procedures	Payer-specific multiple procedure rules
58	Staged or related procedure	Timing and plan not documented
79	Unrelated procedure during postoperative period	Unrelated nature is not clearly supported
RT/LT	Laterality reporting	Mismatch with lesion site documentation

When Modifier 25 Needs Stronger Support

A common denial scenario involves an established patient visit code, such as 99213 or 99214, billed with a biopsy or lesion destruction code. If the record only describes the procedure, the payer may decide the E/M service was included in the procedural work. To support separate billing, the note should document a distinct complaint, assessment, medical decision-making, or management plan beyond the procedure itself.

Repeated Dermatology Denials Can Drain Staff Time

When biopsy, cryotherapy, excision, and E/M denials repeat, your billing team spends more time correcting claims and less time improving collections.

Guarantee: We’ll help organize your denial patterns by code, payer, and root cause.

Get a Free Dermatology Billing Assessment

Lesion Destruction and Excision Denials

Lesion destruction and excision claims require details that are easy to miss during a busy clinic day. Premalignant lesion destruction codes depend on diagnosis and lesion count. Benign lesion destruction claims may require symptoms or medical necessity support. Excision codes require site, size, margin, closure details when relevant, and pathology alignment.

Billing Alignment Check

Review before submission: Lesion type, diagnosis, location, count, size, margin, pathology, modifier use, and payer coverage rules should all support the same claim story.

Why Lesion Details Matter

For destruction codes 17000, 17003, and 17004, the number of treated premalignant lesions affects code selection. For benign lesion destruction codes 17110 and 17111, payers may require clear symptoms or medical necessity. For excision codes 11400-11446 and 11600-11646, the documentation must support the correct benign or malignant code family.

The Same-Lesion Bundling Trap

Biopsy vs. Destruction: A frequent source of immediate denials is billing a biopsy (e.g., 11102) and a destruction code (e.g., 17000) on the exact same lesion on the same day. Under National Correct Coding Initiative (NCCI) edits, the biopsy is considered bundled into the therapeutic destruction unless they were performed on entirely separate anatomical sites. The note must explicitly state they are different lesions to justify separate billing.

Denial Issue	Commonly Affected Codes	What To Verify
Lesion count unclear	17000, 17003, 17004, 17110, 17111	Total lesions treated and treatment sites
Medical necessity missing	17110, 17111	Symptoms, irritation, bleeding, pain, or functional issue
Size or site missing	11400-11446, 11600-11646	Location, excised diameter, margins, and pathology
Pathology mismatch	11400-11446, 11600-11646, 17311, 17312	Diagnosis and pathology support for billed service

Complete documentation supports cleaner claims submission and reduces the need for coder queries, corrected claims, and appeals. It also helps practices identify whether a denial is caused by coding, documentation, or payer coverage limitations.

Mohs, Phototherapy, and Treatment Frequency Denials

Mohs surgery claims may deny when the record does not support diagnosis, anatomic site, stage count, tissue blocks, pathology, or medical necessity. Because Mohs services are higher-value procedures, missing documentation can have a larger financial impact than a routine minor procedure denial.

Mohs Documentation Imperative

The Dual-Role Requirement: Mohs micrographic surgery codes (17311, 17312) explicitly require the operating surgeon to act as both the surgeon and the pathologist. If the medical record does not clearly document that the same physician performed the surgical excision and personally examined the histological slides, the payer will deny the claim or demand a refund during an audit.

Phototherapy codes such as 96910, 96912, and 96913 may deny because of frequency limits, insufficient treatment history, or missing evidence of ongoing need. Payers may expect documentation showing diagnosis, prior treatment, response to therapy, and why continued treatment remains medically reasonable.

Audit Risk Alert

Higher-review services: Mohs, phototherapy, and recurring treatments should be monitored by payer, diagnosis, frequency, and documentation completeness.

Dermatology Billing Needs Specialty-Specific Denial Review

A general denial report may not reveal why lesion, biopsy, Mohs, and phototherapy claims are being denied by different payers.

Guarantee: We’ll help translate denial data into practical next steps for your dermatology billing workflow.

Strengthen Denials Management

Using Denial Data To Improve Dermatology Reimbursement

Dermatology practices can often find reimbursement leakage by reviewing denials by CPT® code, payer, provider, modifier, diagnosis, location, and appeal outcome. A pattern involving 99214 with modifier 25 may suggest same-day E/M documentation gaps. A high denial rate for 11102 may indicate biopsy documentation or add-on coding issues. A payer-specific pattern for 17110 may point to medical necessity policy differences.

Useful Denial Data Points

Track denials by: CPT® code, payer, modifier, diagnosis, provider, location, denial reason, corrected claim outcome, and appeal success rate.

Turning Denial Reports Into Workflow Changes

Denial data is most useful when it leads to action. If the same code denies repeatedly, the practice should determine whether the issue begins with eligibility, authorization, documentation, coding, charge entry, claim scrubbing, payer edits, or follow-up. This helps leaders prioritize fixes instead of treating each denial as an isolated event.

A structured approach to claims management and managing rejected claims can help teams separate quick corrections from denials that require deeper review. When claims qualify for appeal, focused appeals for denied claims can help recover reimbursement and document payer trends.

What Dermatology Practices Should Monitor

The most commonly denied CPT codes in dermatology tend to share a few core issues: insufficient medical necessity documentation, unclear lesion details, incorrect add-on code use, modifier problems, bundling edits, payer frequency limits, and cosmetic coverage disputes. Monitoring these issues can improve first-pass claim performance and reduce avoidable administrative work.

Area To Monitor	Why It Matters	Best Next Step
Modifier 25 usage	Same-day E/M denials are common	Audit E/M notes billed with procedures
Biopsy add-on codes	Incorrect sequencing can trigger edits	Review biopsy type and lesion count documentation
Benign lesion destruction	Cosmetic denials can increase patient disputes	Confirm payer policy and symptom documentation
Excision measurements	Size and site affect code selection	Require complete lesion and margin documentation
Mohs documentation	Higher-value claims face close review	Verify stage, tissue block, map, and pathology support

Need Help Managing Dermatology Denials?

Quest NS helps dermatology practices identify denial trends, strengthen billing workflows, and improve reimbursement performance across high-volume CPT® codes.

Guarantee: We’ll help identify your top denial drivers and provide a clear path forward.

Contact Our Dermatology Billing Specialists

Conclusion

Commonly denied CPT codes in dermatology are often tied to E/M visits, biopsies, lesion destruction, excisions, Mohs surgery, phototherapy, and incision and drainage services. These claims require clear documentation, accurate modifiers, diagnosis support, and payer policy alignment.

By reviewing denial trends by CPT® code, payer, modifier, diagnosis, and appeal outcome, dermatology practices can identify where reimbursement is breaking down and correct the workflow issues behind repeat denials. Strong documentation, clean coding, and specialty-specific billing follow-up all help protect dermatology revenue.

Trademark notice: CPT is a registered trademark of the American Medical Association.

For informational purposes only.